Tetracaine hydrochloride - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for tetracaine hydrochloride and what is the scope of freedom to operate?

Tetracaine hydrochloride is the generic ingredient in one branded drug marketed by Alcon Labs and Bausch Lomb Ireland, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for tetracaine hydrochloride. Six suppliers are listed for this compound.

Summary for tetracaine hydrochloride

US Patents:	0
Tradenames:	1
Applicants:	2
NDAs:	2
Drug Master File Entries:	3
Finished Product Suppliers / Packagers:	6
Raw Ingredient (Bulk) Api Vendors:	98
Clinical Trials:	96
Patent Applications:	4,415
What excipients (inactive ingredients) are in tetracaine hydrochloride?	tetracaine hydrochloride excipients list
DailyMed Link:	tetracaine hydrochloride at DailyMed

Recent Clinical Trials for tetracaine hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Vance Thompson Vision	Early Phase 1
Juerg Hafner	Phase 2
Cutia Therapeutics（Wuxi）Co.,Ltd	Phase 3

See all tetracaine hydrochloride clinical trials

Pharmacology for tetracaine hydrochloride

Drug Class	Ester Local Anesthetic
Physiological Effect	Local Anesthesia

Medical Subject Heading (MeSH) Categories for tetracaine hydrochloride

Anesthetics, Local

Anatomical Therapeutic Chemical (ATC) Classes for tetracaine hydrochloride

US Patents and Regulatory Information for tetracaine hydrochloride

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bausch Lomb Ireland	TETRACAINE HYDROCHLORIDE	tetracaine hydrochloride	SOLUTION;OPHTHALMIC	210821-001	Mar 12, 2019		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Alcon Labs	TETRACAINE HYDROCHLORIDE	tetracaine hydrochloride	SOLUTION;OPHTHALMIC	208135-001	Feb 29, 2016		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.